HIGHLIGHTS
- who: . and colleagues from the University Hospital La Paz, Spain have published the Article: Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagli ozin randomized clinical trial versus real-world data, in the Journal: (JOURNAL)
- what: The authors aimed to investigate to what extent the safety of empagliflozin from the R the authors study in Korea is different from the one in RCT by emulating the design of foreign RCT. The main reason is that clinical trial subjects are of different races. According to the selection . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.